A North Carolina-based company says its
15-minute blood test is already being widely used by the Chinese CDC,
helping officials there to diagnose more patients, faster
On Thursday March 05,2020, that company, BioMedomics, announced its 'quick and easy' test is ready and being used in South Korea,Japan,Italy and some countries in the Middle East.
But the US Food and Drug Administration (FDA) has not approved the test under the emergency measure it announced Saturday Feb 29,2020
Performing this test requires taking
throat and nasal swabs from patients - a rather unpleasant,
uncomfortable process for patient and health care worker alike - and
testing those samples for reactions that indicate they contain the
genetic material of COVID-19
Swabs might be gross, but they're the simplest part of the process
These
types of test are considered the gold-standard for diagnosing
infections diseases, but they involve multiple components, which are
notoriously complex, they have to be run by specially trained
technicians, using specialized equipments.
No comments:
Post a Comment